171 related articles for article (PubMed ID: 14619777)
1. PSA: the plot thickens.
Health News; 2003 Oct; 9(10):15. PubMed ID: 14619777
[No Abstract] [Full Text] [Related]
2. PSA scores: should we use a lower threshold?
Carter HB
Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):6. PubMed ID: 15602780
[No Abstract] [Full Text] [Related]
3. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer.
Boddy JL; Pike DJ; Al-Hayek S; Shaida N; Malone PR
Prostate Cancer Prostatic Dis; 2005; 8(4):349-52. PubMed ID: 16010283
[TBL] [Abstract][Full Text] [Related]
4. [PSA level--is 4.0 ng/ml as upper limit too high].
Aktuelle Urol; 2005 Jun; 36(3):181-8. PubMed ID: 16001334
[No Abstract] [Full Text] [Related]
5. Prostate screening frequency questioned.
Health News; 2002 Jul; 8(7):9. PubMed ID: 12132511
[No Abstract] [Full Text] [Related]
6. The impact of reducing the prostate-specific antigen threshold and including isoform reflex tests on the performance characteristics of a prostate-cancer detection programme.
Roddam AW; Hamdy FC; Allen NE; Price CP;
BJU Int; 2007 Sep; 100(3):514-7. PubMed ID: 17542987
[TBL] [Abstract][Full Text] [Related]
7. The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.
Porter MP; Stanford JL; Lange PH
Prostate; 2006 Jul; 66(10):1044-51. PubMed ID: 16598738
[TBL] [Abstract][Full Text] [Related]
8. Biopsies for "normal" PSA? Certain relatively young, healthy men with PSA levels below 4 should consider having a biopsy.
Gerber GS
Health News; 2004 Jul; 10(7):4-5. PubMed ID: 15239153
[No Abstract] [Full Text] [Related]
9. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
Shao Q; Song J; Zhou ZJ; Du LD
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
[TBL] [Abstract][Full Text] [Related]
10. [Significance of re-measurement of prostate specific antigen before prostate biopsy].
Saito T; Kitamura Y; Komatsubara S
Hinyokika Kiyo; 2006 Oct; 52(10):773-6. PubMed ID: 17131865
[TBL] [Abstract][Full Text] [Related]
11. [Prostate specific antigen and diagnosis of prostate cancer].
Rigaud J; Bouchot O
Rev Prat; 2003 Dec; 53(20):2229-36. PubMed ID: 15018076
[TBL] [Abstract][Full Text] [Related]
12. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
Freedland SJ; Mangold LA; Epstein JI; Partin AW
Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
[TBL] [Abstract][Full Text] [Related]
13. Impact of low prostate specific antigen on prostate cancer--a rare case report.
Schneider HB
Eur J Med Res; 2007 Jul; 12(7):311-3. PubMed ID: 17933704
[TBL] [Abstract][Full Text] [Related]
14. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
Roobol MJ; Kranse R; de Koning HJ; Schröder FH
Urology; 2004 Feb; 63(2):309-13; discussion 313-5. PubMed ID: 14972478
[TBL] [Abstract][Full Text] [Related]
16. [Prostate-specific antigen (PSA)].
Huland H
Urologe A; 1995 Jul; 34(4):273-4. PubMed ID: 7545840
[No Abstract] [Full Text] [Related]
17. [Prostatic punch biopsy].
Braun M; Engelmann U
Aktuelle Urol; 2006 Jul; 37(4):291-302. PubMed ID: 16897646
[No Abstract] [Full Text] [Related]
18. The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.
Fowler FJ; Barry MJ; Walker-Corkery B; Caubet JF; Bates DW; Lee JM; Hauser A; McNaughton-Collins M
J Gen Intern Med; 2006 Jul; 21(7):715-21. PubMed ID: 16808772
[TBL] [Abstract][Full Text] [Related]
19. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].
Li M; Na YQ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):16-8. PubMed ID: 18346372
[TBL] [Abstract][Full Text] [Related]
20. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
Schröder FH; Roobol MJ
Curr Opin Urol; 2009 May; 19(3):227-31. PubMed ID: 19357513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
